期刊文献+

西陵区新冠血清抗体水平监测结果分析

Analysis of Monitoring Results of COVID-19 Serum Antibody Levels in Xiling District
下载PDF
导出
摘要 目的:了解西陵区新冠病毒人群抗体水平变化情况,提前做好防疫物资和医疗资源的准备工作,最大程度保护人民群众生命安全和身体健康,最大限度减少疫情对经济社会发展的影响。方法:采用描述性流行病学方法,对西陵区本地人群新冠血清抗体监测资料进行统计分析。结果:西陵区11月(第四轮)本地人群IgG滴度水平中位数为265.17 AU/mL,较7月(第三轮)同人群IgG滴度水平(302.79 AU/mL)、4月(第二轮)同人群IgG滴度水平(302.60 AU/mL)和3月(第一轮)同人群IgG滴度水平(320.67 AU/mL)均显著下降(P Objective: To understand the change of antibody level of COVID-19 population in Xiling District, prepare epidemic prevention materials and medical resources in advance, protect people’s life safety and health to the greatest extent, and minimize the impact of the epidemic on economic and social development. Methods: Descriptive epidemiological methods were used to statistically analyze the monitoring data of COVID-19 serum antibody in local population in Xiling District. Results: The median IgG titer level of the local population in Xiling District in November (fourth round) was 265.17 AU/mL, which was significantly lower than the IgG titer levels of the same population in July (third round) (302.79 AU/mL), April (second round) (302.60 AU/mL), and March (first round) (320.67 AU/mL) (P < 0.05). Conclusion: The IgG titer level of the local population in Xiling District is still at a high level, the immune barrier has been established, and the accessibility of drugs and medical care is better than before. It is less likely that there will be a medical resource crunch in response to possible infection peaks in the future.
出处 《统计学与应用》 2024年第5期1639-1645,共7页 Statistical and Application
  • 相关文献

参考文献6

二级参考文献44

  • 1Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronovirus as the primary cause of severe acute respiratory syndrome. Lancet, 2003,362:263-270.
  • 2Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronovirus associated with severe acute respiratory syndrome. Science, 2003,300:1394-1399.
  • 3Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med,2003,348:1995-2005.
  • 4Drosten C, Günther S, Preiser W, et al. Identification of a novel coronovirus in patients with severe acute respiratory syndrome. N Engl J Med,2003,348:1967-1976.
  • 5Peiris JSM, Lai ST, Poon LLM, et al. Coronovirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003,361:1319-1325.
  • 6Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronovirus associated with severe acute respiratory syndrome. N Engl J Med, 2003,348:1953-1966.
  • 7Cinatl J, Morgenstern B, Bauer G, et al. Treatment of SARS with human interferons. Lancet, 2003,362:293-294.
  • 8Holmes KV. SARS-associated coronovirus. N Engl J Med, 2003, 348:1948-1951.
  • 9Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronovirus. Science, 2003,300:1399-1404.
  • 10邰平,王进.ELISA法检测梅毒抗体假阳性原因分析及其对策[J].江苏预防医学,2010,21(2):56-57. 被引量:17

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部